Risk of myocardial infarction with increasing quartiles of α2-antiplasmin
| . | Q1 . | Q2 . | Q3 . | Q4 . |
|---|---|---|---|---|
| Cutoff, % | 86 | 93 | 100 | |
| No. of patients | 96 | 128 | 152 | 178 |
| No of control subjects | 163 | 163 | 154 | 155 |
| Model 1: age, OR (95% CI) | 1 | 1.3 (0.9-1.9) | 1.6 (1.2-2.3) | 1.9 (1.3-2.6) |
| Model 2: model 1 + HDL and total cholesterol, OR (95% CI) | 1 | 1.2 (0.8-1.7) | 1.5 (1.0-2.1) | 1.5 (1.0-2.2) |
| Model 3: model 2 + BMI, OR (95% CI) | 1 | 1.2 (0.8-1.7) | 1.5 (1.0-2.1) | 1.5 (1.0-2.2) |
| Model 4: model 3 + plasminogen, OR (95% CI) | 1 | 1.2 (0.8-1.7) | 1.4 (1.0-2.0) | 1.4 (1.0-2.0) |
| . | Q1 . | Q2 . | Q3 . | Q4 . |
|---|---|---|---|---|
| Cutoff, % | 86 | 93 | 100 | |
| No. of patients | 96 | 128 | 152 | 178 |
| No of control subjects | 163 | 163 | 154 | 155 |
| Model 1: age, OR (95% CI) | 1 | 1.3 (0.9-1.9) | 1.6 (1.2-2.3) | 1.9 (1.3-2.6) |
| Model 2: model 1 + HDL and total cholesterol, OR (95% CI) | 1 | 1.2 (0.8-1.7) | 1.5 (1.0-2.1) | 1.5 (1.0-2.2) |
| Model 3: model 2 + BMI, OR (95% CI) | 1 | 1.2 (0.8-1.7) | 1.5 (1.0-2.1) | 1.5 (1.0-2.2) |
| Model 4: model 3 + plasminogen, OR (95% CI) | 1 | 1.2 (0.8-1.7) | 1.4 (1.0-2.0) | 1.4 (1.0-2.0) |
α2-antiplasmin levels were missing for 1 patient.
Q indicates quartile; HDL, high-density lipoprotein; and BMI, body mass index.